Literature DB >> 21294577

Facile syntheses of novel benzo-1,3-dioxolo-, benzothiazolo-, pyrido-, and quinolino-fused 5H-benzo[d]-pyrazolo[5,1-b][1,3]-oxazines and 1H-pyrazoles.

Belem Avila1, Danielle M Solano, Makhluf J Haddadin, Mark J Kurth.   

Abstract

A number of novel benzo-1,3-dioxolo-, benzothiazolo-, pyrido-, and quinolino-fused 5H-benzo[d]pyrazolo[5,1-b][1,3]-oxazines and 1H-pyrazoles were synthesized utilizing an easy and effective N,N-bond forming heterocyclization reaction. In so doing, the substrate scope of this heterocyclization reaction, which starts with o-nitroheterocyclic aldehydes, was expanded to provide several unique heterocyclic compounds for biological screening. This work further demonstrates the versatility of this simple, base-mediated, one-pot heterocyclization method in the construction of novel heterocycles.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21294577      PMCID: PMC3164999          DOI: 10.1021/ol103108z

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  15 in total

1.  Design, synthesis, and SAR of heterocycle-containing antagonists of the human CCR5 receptor for the treatment of HIV-1 infection.

Authors:  D Kim; L Wang; C G Caldwell; P Chen; P E Finke; B Oates; M MacCoss; S G Mills; L Malkowitz; S L Gould; J A DeMartino; M S Springer; D Hazuda; M Miller; J Kessler; R Danzeisen; G Carver; A Carella; K Holmes; J Lineberger; W A Schleif; E A Emini
Journal:  Bioorg Med Chem Lett       Date:  2001-12-17       Impact factor: 2.823

2.  4-(Pyrazol-4-yl)-pyrimidines as selective inhibitors of cyclin-dependent kinase 4/6.

Authors:  Young Shin Cho; Maria Borland; Christopher Brain; Christine H-T Chen; Hong Cheng; Rajiv Chopra; Kristy Chung; James Groarke; Guo He; Ying Hou; Sunkyu Kim; Steven Kovats; Yipin Lu; Marc O'Reilly; Junqing Shen; Troy Smith; Gary Trakshel; Markus Vögtle; Mei Xu; Ming Xu; Moo Je Sung
Journal:  J Med Chem       Date:  2010-11-01       Impact factor: 7.446

3.  Syntheses of potent, selective, and orally bioavailable indazole-pyridine series of protein kinase B/Akt inhibitors with reduced hypotension.

Authors:  Gui-Dong Zhu; Viraj B Gandhi; Jianchun Gong; Sheela Thomas; Keith W Woods; Xiaohong Song; Tongmei Li; R Bruce Diebold; Yan Luo; Xuesong Liu; Ran Guan; Vered Klinghofer; Eric F Johnson; Jennifer Bouska; Amanda Olson; Kennan C Marsh; Vincent S Stoll; Mulugeta Mamo; James Polakowski; Thomas J Campbell; Ruth L Martin; Gary A Gintant; Thomas D Penning; Qun Li; Saul H Rosenberg; Vincent L Giranda
Journal:  J Med Chem       Date:  2007-05-25       Impact factor: 7.446

4.  Synthesis of 2H-indazoles by the [3 + 2] cycloaddition of arynes and sydnones.

Authors:  Chunrui Wu; Yuesi Fang; Richard C Larock; Feng Shi
Journal:  Org Lett       Date:  2010-05-21       Impact factor: 6.005

5.  Synthesis and antihypertensive activity of 4'-substituted spiro[4H-3,1-benzoxazine-4,4'-piperidin]-2(1H)-ones.

Authors:  R D Clark; J M Caroon; A F Kluge; D B Repke; A P Roszkowski; A M Strosberg; S Baker; S M Bitter; M D Okada
Journal:  J Med Chem       Date:  1983-05       Impact factor: 7.446

6.  Claimed 2,1-benzisoxazoles are indazalones.

Authors:  Mark J Kurth; Marilyn M Olmstead; Makhluf J Haddadin
Journal:  J Org Chem       Date:  2005-02-04       Impact factor: 4.354

7.  Rapid access to pyrazolo[3,4-c]pyridines via alkyne annulation: limitations of steric control in nickel-catalyzed alkyne insertions.

Authors:  Stephen T Heller; Swaminathan R Natarajan
Journal:  Org Lett       Date:  2007-11-03       Impact factor: 6.005

8.  New antianginal nitro esters with reduced hypotensive activity. Synthesis and pharmacological evaluation of 3-[(nitrooxy)alkyl]-2H-1,3-benzoxazin-4(3H)-ones.

Authors:  F Benedini; G Bertolini; R Cereda; G Donà; G Gromo; S Levi; J Mizrahi; A Sala
Journal:  J Med Chem       Date:  1995-01-06       Impact factor: 7.446

9.  An oxazolo[3,2-b]indazole route to 1H-indazolones.

Authors:  James S Oakdale; Danielle M Solano; James C Fettinger; Makhluf J Haddadin; Mark J Kurth
Journal:  Org Lett       Date:  2009-07-02       Impact factor: 6.005

10.  An investigation of the reaction of 2-aminobenzaldehyde derivatives with conjugated nitro-olefins: an easy and efficient synthesis of 3-nitro-1,2-dihydroquinolines and 3-nitroquinolines.

Authors:  Ming-Chung Yan; Zhijay Tu; Chunchi Lin; Shengkai Ko; Jianming Hsu; Ching-Fa Yao
Journal:  J Org Chem       Date:  2004-03-05       Impact factor: 4.354

View more
  6 in total

1.  Inhibition of myeloperoxidase: evaluation of 2H-indazoles and 1H-indazolones.

Authors:  Aaron Roth; Sean Ott; Kelli M Farber; Teresa A Palazzo; Wayne E Conrad; Makhluf J Haddadin; Dean J Tantillo; Carroll E Cross; Jason P Eiserich; Mark J Kurth
Journal:  Bioorg Med Chem       Date:  2014-10-02       Impact factor: 3.641

2.  Davis-Beirut Reaction: Diverse Chemistries of Highly Reactive Nitroso Intermediates in Heterocycle Synthesis.

Authors:  Jie S Zhu; Makhluf J Haddadin; Mark J Kurth
Journal:  Acc Chem Res       Date:  2019-07-22       Impact factor: 22.384

3.  The Davis-Beirut reaction: N1,N2-disubstituted-1H-indazolones via 1,6-electrophilic addition to 3-alkoxy-2H-indazoles.

Authors:  Wayne E Conrad; Ryo Fukazawa; Makhluf J Haddadin; Mark J Kurth
Journal:  Org Lett       Date:  2011-05-25       Impact factor: 6.005

4.  A one-pot-three-step route to triazolotriazepinoindazolones from oxazolino-2H-indazoles.

Authors:  Wayne E Conrad; Kevin X Rodriguez; Huy H Nguyen; James C Fettinger; Makhluf J Haddadin; Mark J Kurth
Journal:  Org Lett       Date:  2012-07-23       Impact factor: 6.005

5.  Acid and base catalyzed Davis-Beirut reaction: experimental and theoretical mechanistic studies and synthesis of novel 3-amino-2H-indazoles.

Authors:  Belem Avila; Mohammad H El-Dakdouki; Musa Z Nazer; Jason G Harrison; Dean J Tantillo; Makhluf J Haddadin; Mark J Kurth
Journal:  Tetrahedron Lett       Date:  2012-09-15       Impact factor: 2.415

6.  Davis-Beirut reaction: route to thiazolo-, thiazino-, and thiazepino-2H-indazoles.

Authors:  Kelli M Farber; Makhluf J Haddadin; Mark J Kurth
Journal:  J Org Chem       Date:  2014-07-23       Impact factor: 4.354

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.